IN-SITE #10 briefly covers the meeting with the scientific delegation from Belarus. this delegation has arrived to our office in Uppsala from Minsk in order to update and extend our collaboration agreement and find out more about the secrets of the carrier within the drug Temodex – the novel treatment of brain cancer. One of the members of the delegation, Nikolai, is one of the main researchers behind Temodex recipient (the carrier that makes sure the active substance stays and acts in the right place in the body) was earlier this year performing the technical transfer of Temodex recipient in our contracted manufacturing site in the Netherlands. Find out more about Temodex here.
The trip was sponsored by Eu collaboration programme “MOST”.